| Identification | More | [Name]
Cefuzonam | [CAS]
82219-78-1 | [Synonyms]
1-[[(6r,7r)-7-[[(2z)-(5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-imidazo[1,2-b]pyridazinium hydroxide inner salt
(6r,7s)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CEFUZONAM
Cefuzonam sodium
cefuzoname
(6R,7S)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
[6R-[(6α，7β(Z)]]-7-[[(2-Amino-4-thiazolyl)(methoxy-imino)acetyl]amino]-8-oxo-3-[(1，2，3-thiadiazol-5-yhhio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Cosmosin
LJC-10305
CL-251931
CZON
L-105【Cephem antibiotic】 | [Molecular Formula]
C16H15N7O5S4 | [MDL Number]
MFCD00864878 | [Molecular Weight]
513.59 | [MOL File]
82219-78-1.mol |
| Hazard Information | Back Directory | [Description]
Cefuzonam is an injectable cephalosporin reported to be active against a large percentage
of Gram-negative bacteria and some Gram-positive bacteria, including those resistant to
other third-generation cephdosporins. | [Originator]
Lederle (USA) | [Uses]
Cefuzonam is used for sepsis, acute bronchitis, tonsillitis, secondary infections of traumatic and surgical wounds, pharyngitis, arthritis, etc. caused by susceptible bacteria such as Haemophilus influenzae, Proteus spp., and Escherichia coli. | [Definition]
ChEBI: A second generation cephalosporin antibiotic. | [Brand name]
Cosmosin |
| Safety Data | Back Directory | [Toxicity]
LD50 in female, male mice, female, male rats (mg/kg): 4117, >4800, 4281, 4222 i.v.; 6424, 6783, >8000, >8000 i.p.; all >10000 orally (Takita) |
|
| Company Name: |
AlliChem, LLC
|
| Tel: |
301-317-5072 |
| Website: |
www.allichemllc.com |
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|